Srisomboon J, Piyamongkol W, Aiewsakul P
Department of Obstetrics & Gynaecology, Faculty of Medicine, Chiang Mai University, Thailand.
J Med Assoc Thai. 1997 Mar;80(3):189-94.
To compare the efficacy of intracervical versus intravaginal misoprostol for cervical ripening and labour induction at term in patients with an unfavourable cervix.
A total of 100 pregnant women with indications for induction of labour and unfavourable cervix (Bishop score < or = 4) were randomly assigned to receive either 100 ug misoprostol administered intracervically (50 cases) or intravaginally (50 cases).
No significant differences were noted between intracervical and intravaginal misoprostol in terms of Bishop score change, (score 7.2 vs score 7.5), interval from gel insertion to vaginal delivery (17.0 hours vs 16.4 hours), meperidine as analgesic requirement (80% vs 76%), route of delivery and perinatal outcome. Uterine tachysystole occurred in 24 per cent and 32 per cent in the intracervical and intravaginal groups respectively which did not significantly differ, however, all could be rapidly resolved by terbutaline injection. No evidence of fetal distress was noted in these events. Spillage of gel out of the cervix was observed in 70 per cent of patients receiving intracervical misoprostol. Fever was observed in one patient of each group. No other serious side effects were found in both groups. One patient in the intravaginal group had postpartum hemorrhage due to delayed placental separation and uterine atony.
The two routes of misoprostol gel application appear to be safe and equally effective in ripening cervix and inducing labour, however, the intravaginal application is more convenient to administer practically compared with the intracervical.
比较宫颈内与阴道内使用米索前列醇对宫颈条件不佳的足月孕妇进行促宫颈成熟及引产的疗效。
总共100例有引产指征且宫颈条件不佳(Bishop评分≤4分)的孕妇被随机分为两组,每组50例,分别接受宫颈内给予100μg米索前列醇或阴道内给予100μg米索前列醇。
宫颈内和阴道内使用米索前列醇在Bishop评分变化(分别为7.2分和7.5分)、从放置凝胶至阴道分娩的间隔时间(分别为17.0小时和16.4小时)、哌替啶作为镇痛药物的使用需求(分别为80%和76%)、分娩方式及围产期结局方面均无显著差异。宫颈内给药组和阴道内给药组分别有24%和32%发生子宫收缩过速,两者无显著差异,不过所有病例均可通过注射特布他林迅速缓解。这些事件中未发现胎儿窘迫的证据。接受宫颈内米索前列醇的患者中有70%观察到凝胶从宫颈溢出。每组各有1例患者出现发热。两组均未发现其他严重副作用。阴道内给药组有1例患者因胎盘剥离延迟和子宫收缩乏力发生产后出血。
米索前列醇凝胶的两种给药途径在促宫颈成熟及引产方面似乎同样安全有效,但实际上与宫颈内给药相比,阴道内给药更便于操作。